BMJ Best Practice

参考文献

关键文献

Peitersen E. The natural history of Bell palsy. Am J Otol. 1982;4:107-111.

House JW, Brackmann DE. Facial nerve grading system. Otolaryngol Head Neck Surg. 1985;93:146-147.

Gronseth GS, Paduga R; American Academy of Neurology. Evidence-based guideline update: steroids and antivirals for Bell palsy. Neurology. 2012;79:2209-2213.

Madhok VB, Gagyor I, Daly F, et al. Corticosteroids for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev. 2016;(7):CD001942.

Gagyor I, Madhok VB, Daly F, et al. Antiviral treatment for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev. 2015;(11):CD001869.

Gantz BJ, Rubinstein JT, Gidley P, et al. Surgical management of Bell palsy. Laryngoscope. 1999;109:1177-1188.

Sullivan FM, Swan IR, Donnan PT, et al. Early treatment with prednisolone or acyclovir in Bell's palsy. N Engl J Med. 2007;357:1598-1607.

参考文章

1.  Peitersen E. The natural history of Bell palsy. Am J Otol. 1982;4:107-111.

2.  House JW, Brackmann DE. Facial nerve grading system. Otolaryngol Head Neck Surg. 1985;93:146-147.

3.  Ross BG, Fradet G, Nedzelski JM. Development of a sensitive clinical facial grading system. Otolaryngol Head Neck Surg. 1996;114:380-386.

4.  Banks CA, Bhama PK, Park J, et al. Clinician-graded electronic facial paralysis assessment: the eFACE. Plast Reconstr Surg. 2015;136:223e-230e.

5.  Benatar M, Edlow J. The spectrum of cranial neuropathy in patients with Bell's palsy. Arch Intern Med. 2004;164:2383-2385.

6.  May M, Hardin WB, Sullivan J, et al. Natural history of Bell palsy: the salivary flow test and other prognostic indicators. Laryngoscope. 1976;86:704-712.

7.  Peitersen E. Bell palsy: the spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies. Acta Otolaryngol Suppl. 2002;549:4-30.

8.  Hauser WA, Karnes WE, Annis J, et al. Incidence and prognosis of Bell palsy in the population of Rochester, Minnesota. Mayo Clin Proc. 1971;46:258-264.

9.  Yanagihara N. Incidence of Bell palsy. Ann Otol Rhinol Laryngol. 1988;97:3-4.

10.  Murakami S, Mizobuchi M, Nakashiro Y, et al. Bell palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle. Ann Intern Med. 1996;124(Part 1):27-30.

11.  Esaki S, Yamano K, Katsumi S, et al. Facial nerve palsy after reactivation of herpes simplex virus type 1 in diabetic mice. Laryngoscope. 2015;125:E143-E148.

12.  Kisaki H, Hato N, Mizobuchi M, et al. Role of T-lymphocyte subsets in facial nerve paralysis owing to the reactivation of herpes simplex virus type 1. Acta Otolaryngol. 2005;125:316-321.

13.  Gorodezky C, Carranza JM, Bustamante A, et al. The HLA system and T-cell subsets in Bell palsy. Acta Otolaryngol. 1991;111:1070-1074.

14.  Tekgul H, Polat M, Serdaroglu G, et al. Lymphocyte subsets in Bell palsy: immune pathogenesis and outcome prediction. Pediatr Neurol. 2004;31:258-260.

15.  Townsend JJ, Collins PK. Peripheral nervous system demyelination with herpes simplex virus. J Neuropathol Exp Neurol. 1986;45:419-425.

16.  Fisch U. Surgery for Bell's palsy. Arch Otolaryngol. 1981;107:1-11.

17.  Holland NJ, Weiner GM. Recent developments in Bell's palsy. BMJ. 2004;329:553-557.

18.  Mutsch M, Zhou W, Rhodes P, et al. Use of the inactivated intranasal influenza vaccine and the risk of Bell palsy in Switzerland. N Engl J Med. 2004;350:896-903.

19.  Campbell KE, Brundage JF. Effects of climate, latitude, and season on the incidence of Bell's palsy in the US Armed Forces, October 1997 to September 1999. Am J Epidemiol. 2002;156:32-39.

20.  Brandenburg NA, Annegers JF. Incidence and risk factors for Bell palsy in Laredo, Texas: 1974-1982. Neuroepidemiology. 1993;12:313-325.

21.  Abraham-Inpijn L, Devriese PP, Hart AA. Predisposing factors in Bell palsy: a clinical study with reference to diabetes mellitus, hypertension, clotting mechanism and lipid disturbance. Clin Otolaryngol Allied Sci. 1982;7:99-105.

22.  Hilsinger RL Jr, Adour KK, Doty HE. Idiopathic facial paralysis, pregnancy, and the menstrual cycle. Ann Otol Rhinol Laryngol. 1975;84:433-442.

23.  Gilden DH. Clinical practice. Bell's palsy. N Engl J Med. 2004;351:1323-1331.

24.  Gilden D, Cohrs RJ, Mahalingam R, et al. Neurological disease produced by varicella zoster virus reactivation without rash. Curr Top Microbiol Immunol. 2010;342:243-253.

25.  National Institute of Neurological Disorders and Stroke. Melkersson-Rosenthal syndrome information page. http://www.ninds.nih.gov/ (last accessed 7 September 2017).

26.  Gronseth GS, Paduga R; American Academy of Neurology. Evidence-based guideline update: steroids and antivirals for Bell palsy. Neurology. 2012;79:2209-2213.

27.  Sullivan FM, Swan IR, Donnan PT, et al. A randomised controlled trial of the use of aciclovir and/or prednisolone for the early treatment of Bell's palsy: the BELLS study. Health Technol Assess. 2009;13:1-130.

28.  Hato N, Yamada H, Kohno H, et al. Valacyclovir and prednisolone treatment for Bell's palsy: a multicenter, randomized, placebo-controlled study. Otol Neurotol. 2007;28:408-413.

29.  Engström M, Berg T, Stjernquist-Desatnik A, et al. Prednisolone and valaciclovir in Bell's palsy: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet Neurol. 2008;7:993-1000.

30.  Madhok VB, Gagyor I, Daly F, et al. Corticosteroids for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev. 2016;(7):CD001942.

31.  Gagyor I, Madhok VB, Daly F, et al. Antiviral treatment for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev. 2015;(11):CD001869.

32.  De Diego JI, Prim MP, De Sarriá MJ, et al. Idiopathic facial paralysis: a randomized, prospective, and controlled study using single-dose prednisone versus acyclovir three times daily. Laryngoscope. 1998;108:573-575.

33.  de Almeida JR, Al Khabori M, Guyatt GH, et al. Combined corticosteroid and antiviral treatment for Bell palsy: a systematic review and meta-analysis. JAMA. 2009;302:985-993.

34.  Adour KK, Ruboyianes JM, Von Doersten PG, et al. Bell's palsy treatment with acyclovir and prednisone compared with prednisone alone: a double-blind, randomized, controlled trial. Ann Otol Rhinol Laryngol. 1996;105:371-378.

35.  Gantz BJ, Rubinstein JT, Gidley P, et al. Surgical management of Bell palsy. Laryngoscope. 1999;109:1177-1188.

36.  Sullivan FM, Swan IR, Donnan PT, et al. Early treatment with prednisolone or acyclovir in Bell's palsy. N Engl J Med. 2007;357:1598-1607.

37.  Axelsson S, Berg T, Jonsson L, et al. Prednisolone in Bell's palsy related to treatment start and age. Otol Neurotol. 2011;32:141-146.

38.  Axelsson S, Berg T, Jonsson L, et al. Bell's palsy - the effect of prednisolone and/or valaciclovir versus placebo in relation to baseline severity in a randomised controlled trial. Clin Otolaryngol. 2012;37:283-290.

39.  Berg T, Bylund N, Marsk E, et al. The effect of prednisolone on sequelae in Bell's palsy. Arch Otolaryngol Head Neck Surg. 2012;138:445-449.

40.  Goudakos JK, Markou KD. Corticosteroids vs corticosteroids plus antiviral agents in the treatment of Bell palsy: a systematic review and meta-analysis. Arch Otolaryngol Head Neck Surg. 2009;135:558-564.

41.  Quant EC, Jeste SS, Muni RH, et al. The benefits of steroids versus steroids plus antivirals for treatment of Bell's palsy: a meta-analysis. BMJ. 2009;339:b3354.

42.  McAllister K, Walker D, Donnan PT, et al. Surgical interventions for the early management of Bell's palsy. Cochrane Database Syst Rev. 2013;(10):CD007468.

43.  Baugh RF, Basura GJ, Ishii LE, et al. Clinical practice guideline: Bell's palsy. Otolaryngol Head Neck Surg. 2013;149(3 Suppl):S1-S27.

44.  May M, Klein SR, Taylor FH. Idiopathic (Bell's) facial palsy: natural history defies steroid or surgical treatment. Laryngoscope. 1985;95:406-409.

45.  The College of Optometrists (UK). Facial palsy (including Bell's palsy). March 2016. http://www.college-optometrists.org/ (last accessed 7 September 2017).

46.  Beutner KR, Friedman DJ, Forszpaniak C, et al. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother. 1995;39:1546-1553.

47.  Borodic G, Bartley M, Slattery W, et al. Botulinum toxin for aberrant facial nerve regeneration: double-blind, placebo-controlled trial using subjective endpoints. Plast Reconstr Surg. 2005;116:36-43.

48.  Teixeira LJ, Valbuza JS, Prado GF, et al. Physical therapy for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev. 2011;(12):CD006283.

49.  Beurskens CH, Heymans PG, Oostendorp RA. Stability of benefits of mime therapy in sequelae of facial nerve paresis during a 1-year period. Otol Neurotol. 2006;27:1037-1042.

50.  Pourmomeny AA, Zadmehre H, Mirshamsi M, et al. Prevention of synkinesis by biofeedback therapy: a randomized clinical trial. Otol Neurotol. 2014;35:739-742.

51.  Nicastri M, Mancini P, De Seta D, et al. Efficacy of early physical therapy in severe Bell's palsy: a randomized controlled trial. Neurorehabil Neural Repair. 2013;27:542-551.

52.  Chen N, Zhou M, He L, et al. Acupuncture for Bell's palsy. Cochrane Database Syst Rev. 2010;(8):CD002914.

53.  Holland NJ, Bernstein JM, Hamilton JW, et al. Hyperbaric oxygen therapy for Bell's palsy. Cochrane Database Syst Rev. 2012;(2):CD007288.

54.  Racic G, Denoble PJ, Sprem N, et al. Hyperbaric oxygen as a therapy of Bell's palsy. Undersea Hyperb Med. 1997;24:35-38.

55.  Gillman GS, Schaitkin BM, May M, et al. Bell palsy in pregnancy: a study of recovery outcomes. Otolaryngol Head Neck Surg. 2002;126:26-30.

56.  Shmorgun D, Chan WS, Ray JG. Association between Bell's palsy in pregnancy and pre-eclampsia. QJM. 2002;95:359-362.

使用此内容应接受我们的免责声明